Legal & General Group PLC Vir Biotechnology, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 258,936 shares of VIR stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

258,936

Previous 258,936 -0.0%

Holding current value

$1.85 Million

Previous $1.94 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $17,482 - $25,765	2,408 Added 0.94%	258,936 $1.94 Million
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $39,973 - $66,325	5,239 Added 2.08%	256,528 $2.28 Million
Q1 2024 May 14, 2024	BUY	$8.6 - $11.9 $57,809 - $79,991	6,722 Added 2.75%	251,289 $2.55 Million
Q4 2023 Feb 15, 2024	BUY	$7.76 - $10.29 $6,999 - $9,281	902 Added 0.37%	244,567 $2.46 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $143,333 - $386,090	15,682 Added 6.88%	243,665 $2.28 Million
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $134,119 - $157,763	5,781 Added 2.6%	227,983 $5.59 Million
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $3,049 - $4,226	-137 Reduced 0.06%	222,202 $5.17 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $77,863 - $110,086	3,901 Added 1.79%	222,339 $5.63 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $76,345 - $130,029	4,181 Added 1.95%	218,438 $4.21 Million
Q2 2022 Aug 22, 2022	BUY	$19.08 - $26.7 $3.03 Million - $4.24 Million	158,982 Added 287.62%	214,257 $5.46 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $6,674 - $12,603	315 Added 0.57%	55,275 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $31,775 - $55,434	1,026 Added 1.9%	54,960 $2.3 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $322,964 - $504,713	9,254 Added 20.71%	53,934 $2.35 Million
Q2 2021 Aug 12, 2021	BUY	$38.75 - $51.0 $634,376 - $834,921	16,371 Added 57.83%	44,680 $2.11 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $206,795 - $652,182	-7,851 Reduced 21.71%	28,309 $1.45 Million
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $226,401 - $384,997	8,875 Added 32.53%	36,160 $967,000
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $32,804 - $62,176	-1,160 Reduced 4.08%	27,285 $937,000
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $761,843 - $1.31 Million	27,316 Added 2419.49%	28,445 $1.16 Million
Q1 2020 May 14, 2020	SELL	$12.04 - $60.2 $4,250 - $21,250	-353 Reduced 23.82%	1,129 $39,000
Q4 2019 Feb 13, 2020	BUY	$11.83 - $15.85 $17,532 - $23,489	1,482 New	1,482 $19,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $950M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Vir Biotechnology, Inc. Transaction History